Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticholium Per Se in perioperative sepsis
NCT03013322Completed
- Sponsor
- Heidelberg University Hospital
- Start
- Jan 2015
- Primary completion
- Feb 2017
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of physostigmine in sepsis and septic shock (2 arms), sponsored by Heidelberg University Hospital. Primary endpoint: Sequential Organ Failure Assessment at 14 days. Started Jan 2015; status: completed.
02
Drugs
physostigmine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT03013322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03013322.